COMPANY OVERVIEW

Adicet Bio, Inc. is a well-funded, privately held, preclinical stage biotechnology company that is engaged in the development of cutting-edge immunotherapies that have the potential to profoundly transform the treatment of cancer and other diseases.

---

LOCATION

Menlo Park, CA, USA

Haifa, , Israel

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://www.adicetbio.com

---

CAREER WEBSITE

https://www.adicetbio.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Mar 10, 2021

Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for the Treatment of B Cell Non-Hodgkin's Lymphoma

Aug 5, 2020

Adicet Bio Receives $10 Million Product Development Milestone From Regeneron

Jan 9, 2020

Adicet Bio to Present at J.P. Morgan Healthcare Conference

Oct 2, 2019

Adicet Bio Raises $80M in Series B Financing

Sep 23, 2019

Adicet Bio Appoints Francesco Galimi, M.D., Ph.D., SVP and Chief Medical Officer

For More Press Releases

---